Tulsa OK Dentist Cosmetic General Restorative Dentistry Procedures Announced

Casler Dental Group have announced that they offer a comprehensive range of dental services at their Tulsa office. Dr Conrad Casler and his team provide general, cosmetic and restorative procedures to their patients.

Tulsa, United States - September 13, 2017 /PressCable/ —

The Casler Dental Group have announced that they offer their patients a full range of dental procedures. The Tulsa based dentist offers general, cosmetic and restorative treatments.

For more information please visit the website here: https://www.caslerdentalgroup.com/

Tulsa based Dr Conrad Casler and his highly skilled dental team at Casler Dental Group offer their patients a comprehensive range of general, cosmetic and restorative dental treatments. Dr Casler provides each individual patient with a customized treatment plan and listens closely to their concerns and needs.

The certified and highly experienced dental team uses the las test and most advanced technology, materials and techniques to carry out their range of dental procedures. Dr Casler’s practice is unique in that they can carry out all procedures on site, from general check ups through to complicated cosmetic procedures such as dental implants.

General dentistry and hygiene procedures form the basis of a healthy and strong smile. Casler Dental Group carry out TMJ disorder treatment, root canal therapy, tooth extractions, periodontal therapy and can provide oral appliances and night guards.

Tooth loss or damage can occur for many reasons, including tooth decay, disease or trauma. Dr Casler offers many restorative options to patients to restore full mouth function and an aesthetically pleasing smile. Treatments include crowns, tooth colored fillings, bridges, implants and implant supported dentures, partial dentures, inlays, onlays and full mouth reconstruction. Learn more at https://www.caslerdentalgroup.com/cosmetic-dentistry/porcelain-veneers

Dr Conrad Casler is extensively experienced in cosmetic dentistry and offers a wide variety of treatments. Dr Casler can dramatically improve the appreance of patients smiles, which in turn can improve their confidence. The dental office provides porcelain veneers, teeth whitening, dental bonding and gum contouring among other procedures.

Casler Dental Group’s website features and gallery of before and after photographs of patients who have been treated at the office. There is also an office tour gallery so potential patients can see where Dr Casler and his team carry out their work. Learn more at https://www.caslerdentalgroup.com/dental-implants

Those wishing to find out more can visit the website on the link provided above.

Contact Info:
Name: Dr Conrad Casler
Organization: Casler Dental Group
Address: 6911 S 66th E Ave #300, Tulsa, OK 74133, United States

For more information, please visit https://www.caslerdentalgroup.com/

Source: PressCable

Release ID: 238632

Latest News

EU charges Merck KGaA, GE, Canon of misleading merger info

Nov 22, 2017

By Foo Yun CheeBRUSSELS (Reuters) - General Electric , German drugmaker Merck KGaA , and Japan's Canon risk hefty fines after EU antitrust regulators accused them of providing misleading information during separate merger deals.The European Commission said on Thursday that it had sent three separate charge sheets known as statements of objections to General Electric, Merck KGaA and Canon after investigations showed breaches of the bloc's merger rules.While the charges will not affect the EU approvals of the deals, they could lead to fines up to 1 percent of global revenue for Merck KGaA and General Electric, and up to...

Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion

Nov 22, 2017

By Sam NusseyTOKYO (Reuters) - Konica Minolta Inc said it was purchasing U.S. diagnostics company Ambry Genetics in a deal valued at up to $1 billion - an acquisition that marks a strategic shift for the Japanese firm's healthcare business as it seeks a leading position in precision medicine.The deal is the largest ever for the photocopier maker, which has been seeking to diversify away its office equipment business. It pulled out of cameras about a decade ago.Konica Minolta said its advanced imaging technology complemented privately held Ambry's genetic testing capabilities, with initial applications for combining the technologies seen in...

Oxford BioMedica wins big contract for Novartis cell therapy

Nov 22, 2017

LONDON (Reuters) - Novartis has signed a major contract with Oxford BioMedica that could earn the British company more than $100 million over three years for supplying the Swiss drugmaker with material for its novel cell therapy CTL019.The deal, announced by Oxford BioMedica on Thursday, could help put the veteran biotech firm on a path to sustainable profitability.The contract is for the supply of lentiviral vectors used to generate CTL019, a new kind of treatment for hard-to-treat leukemia that is expected to reach the market this year.A U.S. advisory panel will discuss the case for approving CTL019 at a meeting...

Novartis receives EU approval for Cosentyx label update

Nov 22, 2017

ZURICH (Reuters) - Novartis said that the Committee for Medicinal Products for Human Use (CHMP) has approved a label update for Cosentyx (secukinumab), the first interleukin-17A (IL-17A) approved to treat psoriasis.The label update includes 52 week data from the CLEAR study demonstrating the long-term superiority of Cosentyx versus Stelara (ustekinumab) in psoriasis, a common, non-contagious, auto-immune disease, the Swiss pharmaceutials company said on Thursday. (Reporting by Silke Koltrowitz)

FDA puts hold on Merck multiple myeloma trials after deaths

Nov 22, 2017

(Reuters) - Merck & Co said on Wednesday the U.S. Food and Drug Administration had placed a clinical hold on three multiple myeloma studies testing its Keytruda in combination with other medicines for the blood cancer after more deaths were reported in patients receiving the Merck immunotherapy.The rare setback for Keytruda sent Merck shares more than 1 percent lower.Merck has been on a roll with the medicine, jumping to the front of the pack of companies with new immuno-oncology drugs, particularly after Keytruda extended survival as an initial treatment for advanced lung cancer, by far the largest oncology market. Bristol-Myers...

Search
Top News
You May Need To Know

About Us

The Healthier Web delivers accurate and up-to-date health information through medical content and insights from experts. Feel the ‘ohm’ here in The Healthier Web.

Contact us: sales@thehealthierweb.com